Ulrich Consultants & Investment Group LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Key Points

• Ulrich Consultants & Investment Group bought 4,813 HCA Healthcare shares worth approximately $2.05 million, making HCA its fifth-largest portfolio holding at 2.1% of assets.
• Institutional ownership remains substantial at 62.73%, with major investors including BlackRock, Legal & General, Jupiter Topco, Wellington Management and Bank of America recently adding or increasing positions.
• HCA reported quarterly EPS of $7.59 and revenue of $20.23 billion, beating estimates, while analysts maintain a “Moderate Buy” consensus with an average price target of $467.61. The company also pays a quarterly dividend of $0.78, or $3.12 annually.

Ulrich Consultants & Investment Group LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 4,813 shares of the company's stock, valued at approximately $2,054,000. HCA Healthcare comprises approximately 2.1% of Ulrich Consultants & Investment Group LLC's investment portfolio, making the stock its 5th biggest position.

A number of other hedge funds have also recently made changes to their positions in the stock. BlackRock Inc. acquired a new position in HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. Legal & General Group Plc purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $410,992,000. Jupiter Topco LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $371,138,000. Wellington Management Group LLP increased its stake in HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company's stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in HCA Healthcare during the 2nd quarter worth $238,457,000. Hedge funds and other institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.4%

Shares of HCA Healthcare stock opened at $460.42 on Wednesday. The business's fifty day moving average price is $423.07 and its 200 day moving average price is $419.09. The stock has a market capitalization of $99.68 billion, a P/E ratio of 15.44, a PEG ratio of 1.55 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.84 earnings per share. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare's dividend payout ratio is presently 10.45%.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. BMO Capital Markets assumed coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They set an "outperform" rating and a $495.00 price objective for the company. TD Cowen boosted their price objective on shares of HCA Healthcare from $431.00 to $460.00 and gave the stock a "buy" rating in a report on Monday. Cantor Fitzgerald reiterated an "overweight" rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Sanford C. Bernstein restated a "market perform" rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on shares of HCA Healthcare in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $467.61.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.